Table 7 Risk factors for infection with antibiotic-resistant organisms–VAP
From: Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Variable in VAP (N = 50) | Antimicrobial susceptibility test | Chi-square | ||||
|---|---|---|---|---|---|---|
Sensitive | Resistant | |||||
N | % | N | % | Χ2 | p-value | |
Immunosuppressive drugs | 0 | 0.00 | 4 | 10.26 | 1.226 | 0.268 |
Systemic steroid therapy | 3 | 27.27 | 14 | 35.90 | 0.284 | 0.594 |
Inhaled steroid therapy | 4 | 36.36 | 26 | 66.67 | 3.283 | 0.070 |
Hospitalization of > 2 days in last months | 1 | 9.09 | 7 | 17.95 | 0.501 | 0.479 |
Hospitalization of ≥ 5 days prior NP occurrence | 6 | 54.55 | 22 | 56.41 | 0.012 | 0.912 |
Intravenous antibiotic use within last 3Â months | 3 | 27.27 | 31 | 79.49 | 10.750 | 0.001* |